Transforming Growth Factor-Beta 1 Gene Polymorphisms and Expression in the Blood of Prostate Cancer Patients

By Faria Paula Cristina   Saba Karla   Neves Adriana Freitas   Cordeiro Elisangela Rosa   Marangoni Karina   Freitas Danielo Garcia   Goulart Luiz Ricardo  

Cancer Investigation, Vol. 25, Iss. 8, 2007-11 ,pp. : 726-732

Informa Healthcare

Access to resources Recommend Favorite

A phase I dose-escalation study to a predefined dose of a transforming growth factor-β1 monoclonal antibody (TβM1) in patients with metastatic cancer

By  

International Journal of Oncology, Vol. 45, Iss. 6, 2014-01 ,pp. : 2221-2231

Spandidos Publications

Access to resources Recommend Favorite

Serum follistatin in patients with prostate cancer metastatic to the bone

By Tumminello Francesca   Badalamenti Giuseppe   Fulfaro Fabio   Incorvaia Lorena   Crescimanno Marilena   Flandina Carla   Sepporta Maria   Leto Gaetano  

Clinical and Experimental Metastasis, Vol. 27, Iss. 8, 2010-12 ,pp. : 549-555

Springer Publishing Company

Access to resources Recommend Favorite

Serum sarcosine is a risk factor for progression and survival in patients with metastatic castration-resistant prostate cancer

By Lucarelli Giuseppe   Ditonno Pasquale   Bettocchi Carlo   Spilotros Marco   Rutigliano Monica   Vavallo Antonio   Galleggiante Vanessa   Fanelli Margherita   Larocca Angela Maria Vittoria   Germinario Cinzia Annatea   Maiorano Eugenio   Selvaggi Francesco Paolo   Battaglia Michele  

Future Oncology, Vol. 9, Iss. 6, 2013-06 ,pp. : 899-907

Future Medicine

Access to resources Recommend Favorite

Effect of P-30 protein and tamoxifen on transforming growth factor- 1 in patients with rising prostate specific antigen

By Eid J.E.   Brunner M.   Cummings K.B.   Weiss R.E.   Goodin S.   Aisner J.   Todd M.   DiPaola R.S.  

Urologic Oncology: Seminars and Original Investigations, Vol. 6, Iss. 6, 2001-11 ,pp. : 243-247

Elsevier

Access to resources Recommend Favorite